Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $614,376 - $796,698
-12,600 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $447,039 - $504,225
8,100 Added 180.0%
12,600 $782,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $45,477 - $56,682
900 Added 25.0%
4,500 $249,000
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $215,712 - $248,328
3,600 New
3,600 $228,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Graticule Asia Macro Advisors LLC Portfolio

Follow Graticule Asia Macro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.